These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 33500714

  • 1. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.
    Zhang C, Wang X, Fang D, Xu P, Mo X, Hu C, Abdelatty A, Wang M, Xu H, Sun Q, Zhou G, She J, Xia J, Hui KM, Xia H.
    Theranostics; 2021; 11(5):2108-2122. PubMed ID: 33500714
    [Abstract] [Full Text] [Related]

  • 2. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J, Fan Z, Li J, Yang J, Liu X, Cheng J.
    Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
    [Abstract] [Full Text] [Related]

  • 3. Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma.
    Mok WC, Wasser S, Tan T, Lim SG.
    World J Gastroenterol; 2012 Jul 21; 18(27):3527-36. PubMed ID: 22826617
    [Abstract] [Full Text] [Related]

  • 4. Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1.
    Xu L, Zhu Y, Shao J, Chen M, Yan H, Li G, Zhu Y, Xu Z, Yang B, Luo P, He Q.
    Br J Cancer; 2017 Apr 11; 116(8):1027-1036. PubMed ID: 28267710
    [Abstract] [Full Text] [Related]

  • 5. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
    Wang D, Chang R, Wang G, Hu B, Qiang Y, Chen Z.
    Anticancer Agents Med Chem; 2017 Apr 11; 17(7):948-954. PubMed ID: 27671301
    [Abstract] [Full Text] [Related]

  • 6. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
    Xing Y, Liu Y, Qi Z, Liu Z, Wang X, Zhang H.
    Cell Mol Biol Lett; 2021 Nov 27; 26(1):49. PubMed ID: 34837962
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM, Cao XY, He P, Li J, Feng MX, Zhang YL, Zhang XL, Wang YH, Yang Q, Zhu L, Nie HZ, Jiang SH, Tian GA, Zhang XX, Liu Q, Ji J, Zhu X, Xia Q, Zhang ZG.
    Gastroenterology; 2018 Oct 27; 155(4):1233-1249.e22. PubMed ID: 30009820
    [Abstract] [Full Text] [Related]

  • 8. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z, Qu L, Deng B, Sun X, Wu S, Liao J, Fan J, Peng Z.
    Sci Rep; 2016 Sep 15; 6():33205. PubMed ID: 27628214
    [Abstract] [Full Text] [Related]

  • 9. Knockdown of STK39 suppressed cell proliferation, migration, and invasion in hepatocellular carcinoma by repressing the phosphorylation of mitogen-activated protein kinase p38.
    Chen J, Zhou L, Yang J, Xie H, Liu L, Li Y.
    Bioengineered; 2021 Dec 15; 12(1):6529-6537. PubMed ID: 34519635
    [Abstract] [Full Text] [Related]

  • 10. Hsa-let-7b inhibits cell proliferation by targeting PLK1 in HCC.
    He Z, Deng W, Jiang B, Liu S, Tang M, Liu Y, Zhang J.
    Gene; 2018 Oct 05; 673():46-55. PubMed ID: 29913237
    [Abstract] [Full Text] [Related]

  • 11. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J, Xia C, Pu M, Dai B, Yang X, Shang R, Yang Z, Zhang R, Tao K, Dou K.
    Oncol Rep; 2018 Oct 05; 40(4):1875-1884. PubMed ID: 30015982
    [Abstract] [Full Text] [Related]

  • 12. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
    Li L, Huang K, Zhao H, Chen B, Ye Q, Yue J.
    Cell Cycle; 2020 May 05; 19(10):1236-1252. PubMed ID: 32275843
    [Abstract] [Full Text] [Related]

  • 13. VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Zhangyuan G, Wang F, Zhang H, Jiang R, Tao X, Yu D, Jin K, Yu W, Liu Y, Yin Y, Shen J, Xu Q, Zhang W, Sun B.
    Oncogene; 2020 Feb 05; 39(6):1213-1230. PubMed ID: 31605014
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
    Zhang H, Zhang K, Xu Z, Chen Z, Wang Q, Wang C, Cui J.
    BMC Cancer; 2021 Feb 15; 21(1):163. PubMed ID: 33588776
    [Abstract] [Full Text] [Related]

  • 15. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling.
    Zhuang R, Zhang X, Lu D, Wang J, Zhuo J, Wei X, Ling Q, Xie H, Zheng S, Xu X.
    Mol Carcinog; 2019 Mar 15; 58(3):366-375. PubMed ID: 30362626
    [Abstract] [Full Text] [Related]

  • 16. Long noncoding RNA LINC00324 exerts protumorigenic effects on liver cancer stem cells by upregulating fas ligand via PU box binding protein.
    Gao J, Dai C, Yu X, Yin XB, Zhou F.
    FASEB J; 2020 Apr 15; 34(4):5800-5817. PubMed ID: 32128906
    [Abstract] [Full Text] [Related]

  • 17. cIAP2 via NF-κB signalling affects cell proliferation and invasion in hepatocellular carcinoma.
    Jiang XJ, Chen ZW, Zhao JF, Liao CX, Cai QH, Lin J.
    Life Sci; 2021 Feb 01; 266():118867. PubMed ID: 33310033
    [Abstract] [Full Text] [Related]

  • 18. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
    Qiu J, Zhang S, Wang P, Wang H, Sha B, Peng H, Ju Z, Rao J, Lu L.
    Cancer Med; 2020 Nov 01; 9(21):8159-8172. PubMed ID: 32977361
    [Abstract] [Full Text] [Related]

  • 19. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN, Qiao GL, Yu J, Yang CM, Chen Y, Deng ZF, Song LH, Ma LJ, Yan HL.
    J Exp Clin Cancer Res; 2020 Jun 17; 39(1):114. PubMed ID: 32552766
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF, Sun JP, Hou HT, Li K, Liu X, Ge QX.
    Tumour Biol; 2016 Nov 17; 37(11):15325-15332. PubMed ID: 27704356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.